/PRNewswire/ The global anti-CD20 monoclonal antibodies (mABs) market size is expected to increase by USD 9.05 billion between 2021 and 2026, expanding at a.
/PRNewswire/ CASI Pharmaceuticals, Inc. (Nasdaq: CASI), a U.S. biopharmaceutical company focused on developing and commercializing innovative therapeutics.
Dublin, April 28, 2022 (GLOBE NEWSWIRE) The "The T-cell Lymphoma Market - Size, Share, Outlook, and Opportunity Analysis, 2021 - 2028" report has been.
> Cash position of €17.9 million as of December 31, 2021 > Additional financing of €12 million subscribed by historical shareholders Invus and Financière de la Montagne in the form of the issuance